BHC 250103 12.00C (BHC250103C12000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

BHC250103C12000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 2 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Bausch Health Companies (NYSE:BHC) Shareholders Are up 7.0% This Past Week, but Still in the Red Over the Last Five Years
Simply Wall StJan 1 14:59 ET
Brazil Medical Aesthetics Market Focused Insights 2024-2029: AbbVie, Bausch Health Companies, Candela, Cutera, Cynosure Lutronic, El.En Remain Leading Market Players - ResearchAndMarkets.com
BusinesswireDec 23, 2024 13:39 ET
Is Bausch Health Companies (BHC) Among Billionaire Paul Singer's Top Long-Term Stock Picks?
Yahoo FinanceDec 19, 2024 01:49 ET
Bausch & Lomb Edges Higher After Confirming Sales Process
Seeking AlphaDec 12, 2024 09:13 ET
Bausch Health Says Board Authorized Management To Explore Potential Sale Of Subsidiary Bausch + Lomb; Says Process Is Ongoing. No Decision Has Been Reached
BenzingaDec 12, 2024 07:14 ET
Bausch + Lomb Brief: Says a Potential Sale Is One of Several Options Being Explored to Complete a Full Separation From Bausch Health
MT NewswiresDec 12, 2024 07:05 ET

Comments

Stock Region

Jul 24, 2024 18:51

Health Company Responds To False Rumors Over Bankruptcy Consideration

Bausch Health Responds to Market Rumors.
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) recently found itself at the center of market rumors that suggested the company was considering bankruptcy or insolvency proceedings. These rumors originated from an article issued by Reorg®, citing unnamed sources. In response, Bausch Health has categorically denied these claims, emphasizing that they are unsubstantiated and without merit...

Mcsnacks H Tupack

Jul 24, 2024 12:16

Refutes claim

$Bausch Health (BHC.US)$ See you at 8.00.

Moomoo AI

Jun 22, 2024 08:31

Bausch Health's revenue growth is unimpressive due to its lack of profitability. The share price crash may be an over-reaction, but improvements in business fundamentals are needed before considering a purchase. The company's long-term performance is concerning, and clear growth indicators are required for share price stability.

Strong Week for Bausch Health Companies (NYSE:BHC) Shareholders Doesn't Alleviate Pain of Three-year Loss

Options Newsman

Apr 5, 2024 20:47

Columns Options Market Statistics: TSLA Shares Fall and Options Pop as Reports Suggest the Company Scraps Low-cost Car Plans

News Highlights
$Tesla (TSLA.US)$ shares fell by 3.63%, closing at $164.90. Its options trading volume was 3.83 million. Call contracts account for 48.3% of the total trading volume. The most traded calls are contracts of $170 strike price that expire on Apr. 5th. The total volume reaches 106,470 with an open interest of 29,026. The most traded puts are contracts of a $165 strike p...

Meltyy

Feb 21, 2024 21:25

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?

In today’s market, one of the biggest winners generating outsized interest is $Emergent BioSolutions (EBS.US)$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...